[Clinical consequences of antiphospholipid antibodies in obstetrics and gynecology].

Antiphospholipid antibodies have been reported to be associated with many common clinical settings. Many gynaecologists and obstetricians have suggested their role in the pathogenesis of infertility, recurrent spontaneous abortions (RSA), ectopic pregnancy, intrauterine growth retardation (IURG), intrauterine foetus decay, pregnancy induced hypertension (PIH), preterm rupture of the membranes (PROM) and preterm labour and premature detachment of the placenta and oligohydramnios and abnormalities of the foetus. Based on our trials and many papers it can be assumed that regular treatment, initiated as early as possible, with using acetylsalicylic acid, heparin, prednisone and IgG allows to prevent diseases above-mentioned.